🇺🇸 FDA
Patent

US 8329719

Neuroprotective agents for the prevention and treatment of neurodegenerative diseases

granted A61KA61K31/167A61K31/34

Quick answer

US patent 8329719 (Neuroprotective agents for the prevention and treatment of neurodegenerative diseases) held by Lixte Biotechnology, Inc. expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lixte Biotechnology, Inc.
Grant date
Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/167, A61K31/34, A61K31/4406, A61K31/445